PD-1 endocytosis unleashes the cytolytic potential of check-point blockade in tumor immunity

被引：0
|
作者：
Oroya, Andres [1 ,2 ]
Ben Saad, Elham [1 ]
Bachais, Meriem [1 ]
Rudd, Christopher [1 ]
机构：
[1] Univ Montreal, Hosp Maisonneuve Rosemont, Montreal, PQ, Canada
[2] Univ Montreal, Montreal, PQ, Canada
来源：
JOURNAL OF IMMUNOLOGY | 2024年 / 212卷 / 01期
关键词：
D O I：
10.4049/jimmunol.212.supp.0377.6071
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
    Xin Wang
    Gaochao Guo
    Hui Guan
    Yang Yu
    Jie Lu
    Jinming Yu
    Journal of Experimental & Clinical Cancer Research, 38
  • [42] Evaluation of PD-1 blockade using a multicellular tumor spheroid model
    Zhou, Shujuan
    Zhu, Mei
    Meng, Fanyan
    Shao, Jie
    Xu, Qiuping
    Wei, Jia
    Liu, Baorui
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (12): : 7471 - 7478
  • [43] PD-1 BLOCKADE ENHANCES THE EFFICACY OF ELOTUZUMAB IN MOUSE TUMOR MODELS
    Bezman, N.
    Jhatakia, A.
    Kearney, A.
    Brender, T.
    Maurer, M.
    Sum, C.
    Lei, M.
    Waggie, K.
    Postelnek, J.
    Henning, K.
    Jenkins, M.
    Rogers, A.
    Neeson, P.
    Korman, A.
    Robbins, M.
    Graziano, R.
    HAEMATOLOGICA, 2016, 101 : 161 - 162
  • [44] Tumor specific γδ T cells expand and respond to PD-1 blockade
    Lien, Scott C.
    Ly, Dalam
    Yang, S. Y. Cindy
    Wang, Ben X.
    St Paul, Michael
    Gadalla, Ramy
    Noamani, Babak
    Boross-Harmer, Sarah
    Pugh, Trevor J.
    Spreafico, Anna
    Hirano, Naoto
    Razak, Albiruni R. A.
    Ohashi, Pamela S.
    CANCER IMMUNOLOGY RESEARCH, 2023, 11 (12)
  • [45] The therapeutic potential of PD-1/PD-L1 blockade in smoking exposed emphysema
    Kim, Jiseon
    Kim, Na Hyun
    Shon, Chang-Ho
    Huh, Jin-Young
    Han, Kyung Yeon
    Kim, Kyu-Tae
    Shin, Sun Hye
    Park, Hye Yun
    Lee, Sei Won
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [46] Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
    Wang, Xin
    Guo, Gaochao
    Guan, Hui
    Yu, Yang
    Lu, Jie
    Yu, Jinming
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [47] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [48] Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer
    Yinli Yang
    Ling Li
    Zhansheng Jiang
    Bin Wang
    Zhanyu Pan
    Cancer Immunology, Immunotherapy, 2020, 69 : 2523 - 2532
  • [49] Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade?
    Aruna Nambirajan
    Prit Benny Malgulwar
    Agrima Sharma
    Meher Thej Boorgula
    Ramesh Doddamani
    Manmohan Singh
    Vaishali Suri
    Chitra Sarkar
    Mehar Chand Sharma
    Brain Tumor Pathology, 2019, 36 : 152 - 161
  • [50] Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade?
    Nambirajan, Aruna
    Malgulwar, Prit Benny
    Sharma, Agrima
    Boorgula, Meher Thej
    Doddamani, Ramesh
    Singh, Manmohan
    Suri, Vaishali
    Sarkar, Chitra
    Sharma, Mehar Chand
    BRAIN TUMOR PATHOLOGY, 2019, 36 (04) : 152 - 161
12345